Identifying small-molecule modulators of protein-protein interactions

Area of Science:

• Molecular Biology
• Biochemistry
• Drug Discovery

Background:

• Protein-protein interactions (PPIs) are crucial in cellular processes.
• Disrupting PPIs is a key strategy for developing novel therapeutics.
• Identifying small molecules, such as cyclic peptides, that inhibit PPIs remains challenging.

Purpose of the Study:

• To outline a robust method for identifying cyclic peptides that inhibit protein-protein interactions.
• To adapt a reverse two-hybrid system for screening cyclic peptide libraries.
• To provide detailed protocols for library construction and inhibitor selection.

Main Methods:

• Engineering a reverse two-hybrid system in yeast to link PPI disruption to cell growth.
• Generating randomized cyclic peptide libraries using intein-based plasmid constructs and PCR.
• Transforming libraries into host cells and applying selective conditions to identify inhibitor-producing clones.
• Implementing procedures for genetic selection and validation to minimize false positives.

Main Results:

• Successful identification of cyclic peptides capable of inhibiting specific protein-protein interactions.
• Demonstration of the efficacy of the reverse two-hybrid system for screening peptide libraries.
• Detailed protocols provided for constructing cyclic peptide libraries and optimizing screening conditions.

Conclusions:

• The described reverse two-hybrid system offers an effective platform for discovering cyclic peptide inhibitors of protein-protein interactions.
• This methodology facilitates the development of novel therapeutic agents targeting PPIs.
• The study provides a valuable toolkit for researchers in molecular biology and drug discovery.